Wei Hongyan, Yin Meixian, Lu Yuanzheng, Yang Yan, Li Bo, Liao Xiao-Xing, Dai Gang, Jing Xiaoli, Xiong Yan, Hu Chunlin
1Department of Emergency, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 China.
2NHC Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou, 510080 China.
Cell Death Discov. 2019 Aug 13;5:129. doi: 10.1038/s41420-019-0209-z. eCollection 2019.
Mild hypothermia treatment (MHT) improves the neurological function of cardiac arrest (CA) patients, but the exact mechanisms of recovery remain unclear. Herein, we generated a CA and cardiopulmonary resuscitation (CPR) mouse model to elucidate such function. Naïve mice were randomly divided into two groups, a normothemia (NT) group, in which animals had normal body temperature, and a MHT group, in which animals had a body temperature of 33 °C (range: 32-34 °C), after the return of spontaneous circulation (ROSC), followed by CA/CPR. MHT significantly improved the survival rate of CA/CPR mice compared with NT. Mechanistically, MHT increased the expression of Silent Information Regulator 1 (Sirt1) and decreased P53 phosphorylation (p-P53) in the cortex of CA/CPR mice, which coincided with the elevated autophagic flux. However, Sirt1 deletion compromised the neuroprotection offered by MHT, indicating that Sirt1 plays an important role. Consistent with the observations obtained from in vivo work, our in vitro study utilizing cultured neurons subjected to oxygen/glucose deprivation and reperfusion (OGD/R) also indicated that Sirt1 knockdown increased OGD/R-induced neuron necrosis and apoptosis, which was accompanied by decreased autophagic flux and increased p-P53. However, the depletion of P53 did not suppress neuron death, suggesting that P53 was not critically involved in MHT-induced neuroprotection. In contrast, the application of autophagic inhibitor 3-methyladenine attenuated MHT-improved neuron survival after OGD/R, further demonstrating that increased autophagic flux significantly contributes to MHT-linked neuroprotection of CA/CRP mice. Our findings indicate that MHT improves neurological outcome of mice after CA/CPR through Sirt1-mediated activation of autophagic flux.
轻度低温治疗(MHT)可改善心脏骤停(CA)患者的神经功能,但恢复的确切机制仍不清楚。在此,我们构建了一个CA和心肺复苏(CPR)小鼠模型来阐明这种功能。将未经处理的小鼠随机分为两组,一组为正常体温(NT)组,动物体温正常;另一组为MHT组,动物在自主循环恢复(ROSC)后体温为33°C(范围:32 - 34°C),随后进行CA/CPR。与NT组相比,MHT显著提高了CA/CPR小鼠的存活率。机制上,MHT增加了CA/CPR小鼠皮质中沉默信息调节因子1(Sirt1)的表达并降低了P53磷酸化(p - P53),这与自噬通量增加相一致。然而,Sirt1缺失损害了MHT提供的神经保护作用,表明Sirt1起重要作用。与体内实验结果一致,我们利用经历氧/葡萄糖剥夺和再灌注(OGD/R)的培养神经元进行的体外研究也表明,Sirt1基因敲低增加了OGD/R诱导的神经元坏死和凋亡,同时伴随着自噬通量降低和p - P53增加。然而,P53的缺失并未抑制神经元死亡,表明P53并非MHT诱导的神经保护作用的关键因素。相反,应用自噬抑制剂3 - 甲基腺嘌呤减弱了MHT对OGD/R后神经元存活的改善作用,进一步证明自噬通量增加显著有助于CA/CRP小鼠的MHT相关神经保护作用。我们的研究结果表明,MHT通过Sirt1介导的自噬通量激活改善CA/CPR后小鼠的神经功能结局。